Following the knockdown of ZFHX4 and the overexpression of ZFHX4, there were substantial changes in the expression of SOX2 in glioma cells as determined by RT-PCR (Figure 11B) and Western Blot (Figure 11C) analysis. This evidence concerns the gene ZFHX4 and central nervous system cancer.